Influenza A-associated bronchiolitis obliterans organizing pneumonia mimicking Wegener's granulomatosis

Rheumatology International

Volumn 20, Issue 3, 2001, Pages 125-128

  Staud, R ^a   Ramos, L G ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

ANCA; Influenza A; Pseudovasculitis; Wegener's granulomatosis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; ASSISTED VENTILATION; BRONCHIOLITIS; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INFLUENZA VIRUS A; OPEN LUNG BIOPSY; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME; VIRUS CHARACTERIZATION; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AZATHIOPRINE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOCORTICOIDS; HEMOPTYSIS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MIDDLE AGED; WEGENER GRANULOMATOSIS;

EID: 0035089188     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960000095     Document Type: Article

References (35)

1. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis
2. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis
3. Wegener's granulomatosis, systemic vasculitis, and antineutrophil cytoplasmic autoantibodies
4. Wegener's granulomatosis
5. Pathologic aspects of bronchiolitis obliterans organizing pneumonia
6. Pathologic features of lung biopsy specimens from influenza pneumonia cases
7. Chronic pulmonary complications of early influenza virus in children
8. Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener's granulomatosis. A clinicopathologic study of 16 cases
9. The pathologic spectrum of pulmonary lesions in patients with antineutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase
10. The vasculitides
11. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies
12. c-ANCA positivity in a Belgian patient with pulmonary paracoccidioidomycosis
13. Pitfalls with anti-neutrophil cytoplasmic antibodies (ANCA)
14. Evolving concepts about the role of antineutrophil cytoplasm autoantibodies in systemic vasculitides
15. Antineutrophilic cytoplasmic antibodies (ANCA) and vasculitis
16. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR project for ANCA assay standardization
17. Anti-neutrophil cytoplasmic antibodies (ANCA) in myelodysplasia and other haematological disorders
18. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: Prevalence among patients with high titers of anti-myeloperoxidase antibodies
19. Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA
20. Minocycline-induced autoimmune syndromes: An overview
21. Clinical case seminar: Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature
22. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature
23. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy
24. Drugs associated with vasculitis
25. Endocarditis associated with ANCA
26. The presence of cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA) in the course of subacute bacterial endocarditis with glomerular involvement, coincidence or association?
27. Is vasculitis in subacute bacterial endocarditis associated with ANCA?
28. Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody
29. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis
30. Antineutrophil cytoplasmic antibodies and infection
31. Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections
32. Anticuerpos anticitoplasma de neutrofilos (ANCA) en pacientes infectados por HIV sintomaticos y asintomaticos
33. Anti-neutrophil cytoplasmic autoantibodies in leprosy
34. Anti-neutrophil cytoplasmic antibodies (ANCA) in the clinical forms of leprosy
35. Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection